These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3291307)

  • 1. Tubular vacuolization in kidney graft biopsies in different cyclosporine protocols.
    Hedman L; Svalander C
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):722-4. PubMed ID: 3291307
    [No Abstract]   [Full Text] [Related]  

  • 2. One hundred eighty graft biopsies in cyclosporine-treated kidney transplants.
    Yagisawa T; Takahashi K; Toma H; Teraoka S; Yamaguchi Y; Agishi T; Ota K
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):772-6. PubMed ID: 3291312
    [No Abstract]   [Full Text] [Related]  

  • 3. Isometric tubular vacuolization in renal transplant recipient: the first case report in Thailand.
    Ruangkanchanasetr P; Praechinavong W; Paueksakon P; Satirapoj B; Supasyndh O; Supaporn T
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S168-71. PubMed ID: 22934464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline biopsies define cyclosporine nephrotoxicity.
    Belnap LP; Hammond EH; Yowell R; Richards KF; Rees WV; Stevens LE
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1485. PubMed ID: 2652476
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop.
    Clin Nephrol; 1985 Sep; 24(3):107-19. PubMed ID: 3899437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of acute tubular necrosis on cyclosporine-treated kidney transplants.
    Paramasivan ON; Griffin PJ; Ross WB; Salaman JR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2085. PubMed ID: 3274474
    [No Abstract]   [Full Text] [Related]  

  • 7. A brief review of histopathology in kidney transplant recipients immunosuppressed with cyclosporin A.
    Mihatsch MJ
    Scand J Urol Nephrol Suppl; 1985; 92():95-7. PubMed ID: 3914070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological patterns in cyclosporine-treated renal transplant recipients.
    Mihatsch MJ; Thiel G; Basler V; Ryffel B; Landmann J; von Overbeck J; Zollinger HU
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):101-16. PubMed ID: 3895652
    [No Abstract]   [Full Text] [Related]  

  • 9. Differentiation of cyclosporine A-induced nephrotoxicity from acute rejection in renal transplantation using fine-needle aspiration biopsies.
    Zannier A; Mutin M; Touraine JL; Traeger J
    Transplant Proc; 1987 Oct; 19(5):3630-2. PubMed ID: 3313874
    [No Abstract]   [Full Text] [Related]  

  • 10. An approach to the renal transplant recipient with persistent one-month graft nonfunction.
    Gritsch HA; Koyle MA; Ward HJ; Sender MB; Rajfer J; Cohen AH; Glassock RJ; Mickey MR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1527-8. PubMed ID: 2652492
    [No Abstract]   [Full Text] [Related]  

  • 11. Histopathology of cyclosporine.
    Wallace AC
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):117-22. PubMed ID: 3895653
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine nephrotoxicity.
    Mihatsch MJ; Thiel G; Ryffel B
    Adv Nephrol Necker Hosp; 1988; 17():303-20. PubMed ID: 3124545
    [No Abstract]   [Full Text] [Related]  

  • 13. Isometric tubular epithelial vacuolization in renal allograft biopsy specimens of patients receiving low-dose intravenous immunoglobulin for a positive crossmatch.
    Haas M; Sonnenday CJ; Cicone JS; Rabb H; Montgomery RA
    Transplantation; 2004 Aug; 78(4):549-56. PubMed ID: 15446314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal lesions induced by cyclosporin. Apropos of 4 renal biopsies and 22 necropsies of recipients of heart transplant].
    Chomette G; Auriol M; Beaufils H; Rottembourg A; Cabrol C
    Ann Pathol; 1986; 6(1):29-36. PubMed ID: 3521626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritubular capillary congestion in renal allograft biopsies may be an unreliable marker for cyclosporine nephrotoxicity.
    Alpers CE; Christopher TG; Mallea M
    Am J Kidney Dis; 1991 Sep; 18(3):413-5. PubMed ID: 1882839
    [No Abstract]   [Full Text] [Related]  

  • 16. Is cyclosporine-associated nephrotoxicity progressive?
    Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P
    Transplant Proc; 1987 Oct; 19(5):4031-2. PubMed ID: 3313992
    [No Abstract]   [Full Text] [Related]  

  • 17. Five-year serial renal graft biopsy study in cyclosporine-treated patients.
    Wilczek H; Bohman SO; Klintmalm G; Groth CG
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):812-5. PubMed ID: 3291319
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cyclosporin A--new perspectives in transplantation surgery].
    Margreiter R; Huber C; Borel JF
    Wien Med Wochenschr; 1983; 133 Suppl 1():37-42. PubMed ID: 6362212
    [No Abstract]   [Full Text] [Related]  

  • 19. Reflections on use of the renal biopsy as the "gold standard" in distinguishing transplant rejection from cyclosporine nephrotoxicity.
    Solez K; McGraw DJ; Beschorner WE; Kone BC; Racusen LC; Whelton A; Burdick JF
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):123-33. PubMed ID: 3927535
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine use in early graft dysfunction.
    Gonwa TA; Nghiem DD; Schulak JA; Corry RJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):104-12. PubMed ID: 3515675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.